XML 70 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Equity - Warrants (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 22, 2020
Apr. 20, 2020
Jul. 17, 2019
May 31, 2016
Jun. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Warrant              
Number of Underlying Shares              
Outstanding, beginning balance (in shares)           17,403,846 14,653,846
Outstanding, end balance (in shares)           14,303,846 17,403,846
Weighted Average Exercise Price Per Share              
Outstanding, beginning balance (in dollars per share)           $ 0.38 $ 0.39
Outstanding, end balance (in dollars per share)           $ 0.39 $ 0.38
May 2016 Warrants              
Number of Underlying Shares              
Exchanged during period (in shares)             4,500,000
Series B Warrants              
Number of Underlying Shares              
Exchanged during period (in shares)             4,500,000
Weighted Average Exercise Price Per Share              
Exchanged during the period (in dollar per share)             $ 0.35
Warrants exercise period     6 months        
July 2019 Series A warrants              
Number of Underlying Shares              
Exercised (in shares)           (200,000)  
Weighted Average Exercise Price Per Share              
Exercised during period (in dollar per share)           $ 0.35  
July 2019 Series B warrants              
Number of Underlying Shares              
Exercised (in shares)           (1,500,000)  
Weighted Average Exercise Price Per Share              
Exercised during period (in dollar per share)           $ 0.35  
April 2020 Series A warrants              
Number of Underlying Shares              
Granted (in shares)             7,500,000
Exercised (in shares)           (1,400,000) (5,000,000)
Weighted Average Exercise Price Per Share              
Granted (in dollars per share)             $ 0.30
Exercised during period (in dollar per share)           $ 0.30 $ 0.30
April 2020 Series B warrants              
Number of Underlying Shares              
Granted (in shares)             3,750,000
Exercised (in shares)             (3,500,000)
Weighted Average Exercise Price Per Share              
Granted (in dollars per share)             $ 0.30
Exercised during period (in dollar per share)             $ 0.30
Private Placement | Series A Warrants              
Number of Underlying Shares              
Exercised (in shares)           6,400,000 6,400,000
Outstanding, end balance (in shares)           1,100,000  
Private Placement | Series B Warrants              
Number of Underlying Shares              
Exercised (in shares)           3,500,000 3,500,000
Outstanding, end balance (in shares)           250,000  
Registered Offering              
Weighted Average Exercise Price Per Share              
Stock Issued During period Shares New Issues       8,000,000.0      
Sale price (in dollars per shares)       $ 0.50      
Gross proceeds from common stock sale       $ 4.0      
Registered Offering | May 2016 Warrants              
Number of Underlying Shares              
Outstanding, end balance (in shares)           1,500,000  
Registered Offering | Series A Warrants              
Number of Underlying Shares              
Exercised (in shares)           200,000  
Outstanding, end balance (in shares)           8,453,846  
Weighted Average Exercise Price Per Share              
Warrants exercise period     6 months        
Registered Offering | Series B Warrants              
Number of Underlying Shares              
Exercised (in shares)           1,500,000  
Outstanding, end balance (in shares)           3,000,000  
Registered Offering | 2016 Warrants              
Number of Underlying Shares              
Outstanding, end balance (in shares)       6,000,000      
Weighted Average Exercise Price Per Share              
Number of shares of common stock per capital unit (in shares)       0.75      
Number of common shares which can be purchased with each warrant       1      
Warrants exercise period       5 years      
LPC Program [Member]              
Weighted Average Exercise Price Per Share              
Stock Issued During period Shares New Issues           900,000  
Sale price (in dollars per shares)           $ 0.27  
Common Stock | Private Placement              
Weighted Average Exercise Price Per Share              
Stock Issued During period Shares New Issues   15,000,000     15,000,000    
Common shares issuable upon exercise   11,250,000          
Common Stock | Private Placement | Series A Warrants              
Weighted Average Exercise Price Per Share              
Common shares issuable upon exercise   7,500,000          
Common Stock | Private Placement | Series B Warrants              
Weighted Average Exercise Price Per Share              
Outstanding, end balance (in dollars per share) $ 0.26            
Common shares issuable upon exercise   3,750,000          
Common Stock | Registered Offering              
Weighted Average Exercise Price Per Share              
Stock Issued During period Shares New Issues     8,653,846